Last edition
News about "Sequencing technology "
Strand Life Sciences Develops Prenatal Genomic Diagnostics Portfolio
Strand Life Sciences has developed its prenatal screening and diagnostics portfolio with two breakthrough technologies: CNSeq (for identification of aneuploidies and copy number variations) and MaatriSeq (Non-Invasive Prenatal Screening).
Sequencing Technology | 24/04/2024 | By Aishwarya | 388
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members